VESICARE - Medsafe
VESICARE Solifenacin succinate Version: 2.0 2 4.3 Contraindications 1. Hypersensitivity to the active substance or to any of the excipients.
Download VESICARE - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Drug List by Therapeutic Category - ClinCalc.com
clincalc.comDrug List by Therapeutic Category Cardiovascular Drugs 01.01 – Renin–Angiotensin– Aldosterone System (RAAS) 1. Lisinopril (Prinivil, Zestril) 2. Lisinopril/hydrochlorothiazide (Prinzide, Zestoretic)
APIs – CEP / EDMF / Technical package available
www.fa-pharma.comapis – cep / edmf / technical package available product name documentation status abacavir sulphate edmf ctd acamprosate calcium edmf ctd acarbose cep acebutolol hcl cep aceclofenac cep acemetacin edmf ctd aciclovir cep adapalene edmf ctd adefovir dipivoxil edmf ctd afloqualone edmf ctd albuterol sulphate edmf ctd alendronic acid sodium salt (sodium alendronate) cep ...
API Product List - Jubilant Life Sciences
www.jubl.comAPI Product List DMFs Filed Alendronate Sodium Aripiprazole Atorvastatin Amorphous Azithromycin Dihydrate Azithromycin Monohydrate Bupropion Hydrochloride
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Astellas …
www.astellas.usFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE VESIcare® is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. 2 DOSAGE AND ADMINISTRATION
願景：軍民之首選醫院、社區健康守護者、國際級醫學中心。 …
www1.ndmctsgh.edu.twTi 三 軍 總 醫 院 Trri--SSeerrvviiccee GGeenneerraall HHoossppiittaall 宗旨：發揚優良傳統，提供軍民最優質的醫療服務。 願景：軍民之首選醫院、社區健康守護者、國際級醫學中心。